|
AU2016222458A1
|
|
Compositions containing Nucleosides and Manganese and their Uses
|
|
AU2016216577A1
|
|
Codon optimized IL-15 and IL-15R-alpha genes for expression in mammalian cells
|
|
AU2014200523A1
|
|
Compositions containing Nucleosides and Manganese and their Uses
|
|
AU2013213749A1
|
|
Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virus
|
|
AU2013201187A1
|
|
Neuronal avalanche assay
|
|
AU2012242784A1
|
|
Peptide mimetic ligands of polo-like kinase 1 polo box domain and methods of use
|
|
AU2012201107A1
|
|
Functional epitopes of Streptococcus pneumoniae PsaA antigen and uses thereof
|
|
AU2012200557A1
|
|
Human monoclonal antibodies against Hendra and Nipah viruses
|
|
AU2011265315A1
|
|
Methods related to the treatment of neurodegenerative and inflammatory conditions
|
|
AU2011232787A1
|
|
Peptide vaccines against group A streptococci
|
|
AU2008296241A1
|
|
Thermal inactivation of rotavirus
|
|
AU2008203277A1
|
|
Peptide vaccines against group A streptococci
|
|
AU2007201878A1
|
|
Retrovirus isolated from humans
|
|
AU2006202361A1
|
|
Human P53 mutations and a genetic system in yeast for functional identification of human P53 mutations
|
|
AU2006244151A1
|
|
Methods and compositions for detecting immune responses
|
|
AU2006201192A1
|
|
CD40 ligand adjuvant for respiratory syncytial virus
|
|
AU2006213996A1
|
|
Methods for detecting progression of low grade cervical dysplasia and for detecting adenocarcinomas
|
|
AU2006210792A1
|
|
Papillomavirus L2 N-terminal peptides for the induction of broadly cross-neutralizing antibodies
|
|
AU2005332058A1
|
|
Functional epitopes of Streptococcus pneumoniae PsaA antigen and uses thereof
|
|
AU2005201556A1
|
|
Methods and compositions for detecting larval taenia solium with a cloned diagnostic antigen
|
